ArticleROLE OF INTERLEUKIN-17 IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C VIRUS LIVER CIRRHOSIS
ArticleROLE OF INTERLEUKIN-17 IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C VIRUS LIVER CIRRHOSIS
ArticleRole of Interleukin-28 B Gene Polymorphism and Cytomegalovirus Coinfection in Hepatocellular Carcinoma Patients with Chronic Hepatitis C Virus
ArticleRole of Interleukin-28 B Gene Polymorphism and Cytomegalovirus Coinfection in Hepatocellular Carcinoma Patients with Chronic Hepatitis C Virus
ArticleRelation between Interleukin -4 (590C/T) Gene Polymorphism and Hepatocellular Carcinoma Risk in HBV and HCV Patients
ArticleRelation between Interleukin -4 (590C/T) Gene Polymorphism and Hepatocellular Carcinoma Risk in HBV and HCV Patients
ArticleThe role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B
ArticleThe role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B
ThesisStudy of serum level of interleukin 8 in patients with chronic liver disease due to hepatitis C with and without hepatocellular carcinoma
ThesisStudy of serum level of interleukin 8 in patients with chronic liver disease due to hepatitis C with and without hepatocellular carcinoma
ArticleSERUM INTERLEUKIN-22 AS A MARKER OF DECOMPENSATED LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN CHRONIC HCV PATIENTS
ArticleSERUM INTERLEUKIN-22 AS A MARKER OF DECOMPENSATED LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN CHRONIC HCV PATIENTS
ArticleEffect of hepatitis C virus infection on the circulating levels of interleukin (IL)-22, IL-32 and IL-34 in non-Hodgkin lymphoma patients
ArticleEffect of hepatitis C virus infection on the circulating levels of interleukin (IL)-22, IL-32 and IL-34 in non-Hodgkin lymphoma patients
ArticleThe Role of Interleukin-17 and Toll-Like Receptor 4 Gene Polymorphisms in Patients with Hepatitis C Virus and Hepatocellular Carcinoma
ArticleThe Role of Interleukin-17 and Toll-Like Receptor 4 Gene Polymorphisms in Patients with Hepatitis C Virus and Hepatocellular Carcinoma